NRX Pharmaceuticals (NRXP)

NRX Pharmaceuticals (NRXP) Cash flow


NRX Pharmaceuticals Cash Flow

NRXP's free cash flow for Q4 2023 was $-3.67M. For the 2023 fiscal year, NRXP's free cash flow was decreased by $18.11M and operating cash flow was $-3.67M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -20.76M$ -21.66M$ -39.76M$ -37.70M$ -2.27M
Investing Cash Flow
$ -1.00K$ -3.00K$ -10.00K$ -7.00K$ -2.00K
Financing Cash Flow
$ 8.10M$ 6.20M$ 32.21M$ 63.46M$ 3.25M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 35.53M$ 4.59M$ 20.05M$ 27.61M$ 1.86M
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
$ 818.00K$ 885.00K---
Issuance Of Capital Stock
---$ 11.05M$ 2.63M
Issuance Of Debt
--$ 9.50M$ -1.28M$ 620.00K
Repayment Of Debt
--$ -518.00K$ -1.28M$ 0.00
Free Cash Flow
$ -20.77M$ -21.66M$ -39.77M$ -37.71M$ -2.27M
Domestic Sales
Foreign Sales
Currency in USD

NRX Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis